BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18980247)

  • 1. DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.
    Lee MY; Ajjappala BS; Kim MS; Oh YK; Baek KH
    J Cell Biochem; 2008 Dec; 105(6):1420-9. PubMed ID: 18980247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.
    Baek KH
    Am J Hematol; 2002 Dec; 71(4):340-5. PubMed ID: 12447969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway.
    Bogusz AM; Brickley DR; Pew T; Conzen SD
    FEBS J; 2006 Jul; 273(13):2913-28. PubMed ID: 16817852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential regions of deubiquitinating enzyme activity and enhancer function for DUB-2A expressed in T-lymphocytes.
    Baek KH; Kim YS; Lee HJ; Kang I
    Arch Biochem Biophys; 2004 Oct; 430(2):191-7. PubMed ID: 15369818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical regions for deubiquitinating activity of DUB-2 expressed in T-lymphocytes.
    Lee JH; Kim YS; Kim M; Baek KH
    Am J Hematol; 2001 Aug; 67(4):270-2. PubMed ID: 11443643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genomic and functional inventory of deubiquitinating enzymes.
    Nijman SM; Luna-Vargas MP; Velds A; Brummelkamp TR; Dirac AM; Sixma TK; Bernards R
    Cell; 2005 Dec; 123(5):773-86. PubMed ID: 16325574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation and deconjugation of ubiquitin regulating the destiny of proteins.
    Baek KH
    Exp Mol Med; 2003 Feb; 35(1):1-7. PubMed ID: 12642897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Cidea protein stability by the ubiquitin-mediated proteasomal degradation pathway.
    Chan SC; Lin SC; Li P
    Biochem J; 2007 Dec; 408(2):259-66. PubMed ID: 17711404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-regulated protein degradation by the ubiquitination system.
    Baek KH
    Curr Protein Pept Sci; 2006 Apr; 7(2):171-7. PubMed ID: 16611142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.
    Baek KH; Kim MS; Kim YS; Shin JM; Choi HK
    J Biol Chem; 2004 Jan; 279(4):2368-76. PubMed ID: 14583620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitinating enzyme USP36 contains the PEST motif and is polyubiquitinated.
    Kim MS; Kim YK; Kim YS; Seong M; Choi JK; Baek KH
    Biochem Biophys Res Commun; 2005 May; 330(3):797-804. PubMed ID: 15809067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of the common cytokine receptor gammac and regulation of expression by an ubiquitination/deubiquitination machinery.
    Gesbert F; Malardé V; Dautry-Varsat A
    Biochem Biophys Res Commun; 2005 Aug; 334(2):474-80. PubMed ID: 16004964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EKLF/KLF1 is ubiquitinated in vivo and its stability is regulated by activation domain sequences through the 26S proteasome.
    Quadrini KJ; Bieker JJ
    FEBS Lett; 2006 Apr; 580(9):2285-93. PubMed ID: 16579989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells.
    Tan F; Lu L; Cai Y; Wang J; Xie Y; Wang L; Gong Y; Xu BE; Wu J; Luo Y; Qiang B; Yuan J; Sun X; Peng X
    Proteomics; 2008 Jul; 8(14):2885-96. PubMed ID: 18655026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.
    Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I
    J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.
    Baek KH; Mondoux MA; Jaster R; Fire-Levin E; D'Andrea AD
    Blood; 2001 Aug; 98(3):636-42. PubMed ID: 11468161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadmium interferes with the degradation of ATF5 via a post-ubiquitination step of the proteasome degradation pathway.
    Uekusa H; Namimatsu M; Hiwatashi Y; Akimoto T; Nishida T; Takahashi S; Takahashi Y
    Biochem Biophys Res Commun; 2009 Mar; 380(3):673-8. PubMed ID: 19285020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HP-Lattice QSAR for dynein proteins: experimental proteomics (2D-electrophoresis, mass spectrometry) and theoretic study of a Leishmania infantum sequence.
    Dea-Ayuela MA; Pérez-Castillo Y; Meneses-Marcel A; Ubeira FM; Bolas-Fernández F; Chou KC; González-Díaz H
    Bioorg Med Chem; 2008 Aug; 16(16):7770-6. PubMed ID: 18662882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.
    Zhu Y; Lambert K; Corless C; Copeland NG; Gilbert DJ; Jenkins NA; D'Andrea AD
    J Biol Chem; 1997 Jan; 272(1):51-7. PubMed ID: 8995226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ZnS semiconductor nanoparticles capped with various functional groups as the matrix and affinity probes for rapid analysis of cyclodextrins and proteins in surface-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Kailasa SK; Kiran K; Wu HF
    Anal Chem; 2008 Dec; 80(24):9681-8. PubMed ID: 18991387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.